Fear of Unpredictability: Industry Criticises Japan’s Frequent Pricing Rule Changes

United Call For Reforms

While Japan enters annual drug price revisions with frequent regulation changes, several major corporate players in the country warn again that government policies mean that the country is at risk of “losing attractiveness.”

Japan's frequent regulation changes
Japan's frequent changes to drug pricing rules provoke discussions • Source: Shutterstock

Pharmaceutical Research and Manufacturers of America (PhRMA), the Japan Pharmaceutical Manufacturers Association (JPMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have made a joint statement for the first time on the need for Japan to improve its policies related to the biopharmaceutical industry.

During a PhRMA press conference in Tokyo held the same day as the 16 May statement, the US group urged...

More from Japan

More from Asia